Managing atherogenic dyslipidaemia and diabetic retinopathy in type 2 diabetes
Description
In this Product Explainer, Endocrinologist Prof Richard O’Brien explains the role of Fenofibrate in reducing the progression of diabetic retinopathy in patients with type 2 diabetes (5 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Dr Sushil Pant
Acutely Painful Shoulder – Assessment and Management in GP
Dr Richard Phoon
Chronic Kidney Disease – Delay Progression and Prevent Dialysis
Prof Rodney Baber AM
Understand & Explain the Risks & Side Effects of MHT
Prof Peter Richmond
Invasive Pneumococcal Disease – What GPs Need to Know
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
Endocrinologist; Clinical Dean of Medicine, University of Melbourne, Austin Clinical School; Director of Graduate Programs, Melbourne Medical School; Senior Endocrinologist and Director, Lipid Service, Austin Health
